GHK-Cu exhibits some potential to influence various biological pathways, including an apparent induction of tissue repair, attraction of immune cells, antioxidant and anti-inflammatory characteristics, activation of collagen and glycosaminoglycan synthesis in skin fibroblasts, regulation of extracellular matrix components like decorin, and possible promotion of blood vessel growth
Thymosin Beta-4 is a naturally occurring 43-amino-acid peptide produced primarily by the thymus gland and found in almost every cell in the human body, with the highest concentrations in platelets and wound fluid
So I think seeing the progression of that and looking at outcome studies will be key before we make a decision of whether or not we want to include that in our care. Road to Reimbursement Because GLP-1s are a new drug within health care in general and there are not yet any clinical standards for its use across substance use disorder care, serious mental illnesses or eating disorders, the road to eventual reimbursement for including it in care is one all practitioners told BHB they will be closely monitoring
***Zwischen der Versandapotheke DocMorris und den DocMorris Vor-Ort-Apotheken besteht keine rechtliche oder wirtschaftliche Verbindung